vs
BKV Corp（BKV）与Sarepta Therapeutics, Inc.（SRPT）财务数据对比。点击上方公司名可切换其他公司
Sarepta Therapeutics, Inc.的季度营收约是BKV Corp的1.4倍（$369.6M vs $255.9M），BKV Corp净利率更高（27.5% vs -111.5%，领先139.0%）
BKV Corp是一家北美独立能源企业，专注于天然气的可持续勘探、生产与配送，核心运营资产位于阿巴拉契亚盆地，服务区域内公用事业、工业及商业客户，同时投资碳捕获等低碳技术以降低运营排放。
Sarepta Therapeutics是一家总部位于美国马萨诸塞州剑桥的生物医药企业，专注于医学研究与药物研发。公司成立于1980年，前身为AntiVirals，后续先后更名为AVI BioPharma及现名，截至2023年已有四款获批上市药物，在相关疾病治疗领域深耕技术创新。
BKV vs SRPT — 直观对比
营收规模更大
SRPT
是对方的1.4倍
$255.9M
净利率更高
BKV
高出139.0%
-111.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $255.9M | $369.6M |
| 净利润 | $70.4M | $-412.2M |
| 毛利率 | — | — |
| 营业利润率 | 39.3% | -111.4% |
| 净利率 | 27.5% | -111.5% |
| 营收同比 | — | -42.1% |
| 净利润同比 | — | -359.2% |
| 每股收益（稀释后） | $0.78 | $-3.92 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BKVSRPT
| Q4 25 | $255.9M | $369.6M | ||
| Q3 25 | $199.8M | $370.0M | ||
| Q2 25 | $207.1M | $513.1M | ||
| Q1 25 | $231.0M | $611.5M | ||
| Q4 24 | — | $638.2M | ||
| Q3 24 | $133.5M | $429.8M | ||
| Q2 24 | — | $360.5M | ||
| Q1 24 | — | $359.5M |
净利润BKVSRPT
| Q4 25 | $70.4M | $-412.2M | ||
| Q3 25 | $76.8M | $-50.6M | ||
| Q2 25 | $104.6M | $196.9M | ||
| Q1 25 | $-78.7M | $-447.5M | ||
| Q4 24 | — | $159.0M | ||
| Q3 24 | $12.9M | $33.6M | ||
| Q2 24 | — | $6.5M | ||
| Q1 24 | — | $36.1M |
毛利率BKVSRPT
| Q4 25 | — | — | ||
| Q3 25 | — | 59.3% | ||
| Q2 25 | — | 70.3% | ||
| Q1 25 | — | 77.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 78.7% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.9% |
营业利润率BKVSRPT
| Q4 25 | 39.3% | -111.4% | ||
| Q3 25 | 41.2% | -27.9% | ||
| Q2 25 | 62.0% | 22.5% | ||
| Q1 25 | -40.6% | -49.1% | ||
| Q4 24 | — | 25.3% | ||
| Q3 24 | -15.7% | 5.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | 9.7% |
净利率BKVSRPT
| Q4 25 | 27.5% | -111.5% | ||
| Q3 25 | 38.5% | -13.7% | ||
| Q2 25 | 50.5% | 38.4% | ||
| Q1 25 | -34.1% | -73.2% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 9.6% | 7.8% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 10.0% |
每股收益（稀释后）BKVSRPT
| Q4 25 | $0.78 | $-3.92 | ||
| Q3 25 | $0.90 | $-0.50 | ||
| Q2 25 | $1.23 | $1.89 | ||
| Q1 25 | $-0.93 | $-4.60 | ||
| Q4 24 | — | $1.56 | ||
| Q3 24 | $0.18 | $0.34 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.4M | $939.6M |
| 总债务越低越好 | $486.8M | $829.0M |
| 股东权益账面价值 | $2.0B | $1.1B |
| 总资产 | $3.1B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.24× | 0.73× |
8季度趋势，按日历期对齐
现金及短期投资BKVSRPT
| Q4 25 | $199.4M | $939.6M | ||
| Q3 25 | $83.1M | $851.0M | ||
| Q2 25 | $21.4M | $800.1M | ||
| Q1 25 | $15.3M | $522.8M | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $31.3M | $1.2B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.4B |
总债务BKVSRPT
| Q4 25 | $486.8M | $829.0M | ||
| Q3 25 | $486.6M | $140.5M | ||
| Q2 25 | $200.0M | — | ||
| Q1 25 | $200.0M | — | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $190.0M | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
股东权益BKVSRPT
| Q4 25 | $2.0B | $1.1B | ||
| Q3 25 | $1.8B | $1.3B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.5B | $1.1B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $961.2M |
总资产BKVSRPT
| Q4 25 | $3.1B | $3.3B | ||
| Q3 25 | $2.9B | $3.5B | ||
| Q2 25 | $2.3B | $3.7B | ||
| Q1 25 | $2.3B | $3.5B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | $2.3B | $3.6B | ||
| Q2 24 | — | $3.4B | ||
| Q1 24 | — | $3.2B |
负债/权益比BKVSRPT
| Q4 25 | 0.24× | 0.73× | ||
| Q3 25 | 0.27× | 0.11× | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 0.12× | 1.01× | ||
| Q2 24 | — | 1.14× | ||
| Q1 24 | — | 1.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $69.4M | $131.2M |
| 自由现金流经营现金流 - 资本支出 | — | $127.6M |
| 自由现金流率自由现金流/营收 | — | 34.5% |
| 资本支出强度资本支出/营收 | — | 1.0% |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $-307.5M |
8季度趋势，按日历期对齐
经营现金流BKVSRPT
| Q4 25 | $69.4M | $131.2M | ||
| Q3 25 | $74.5M | $-14.6M | ||
| Q2 25 | $76.2M | $261.3M | ||
| Q1 25 | $22.6M | $-583.4M | ||
| Q4 24 | — | $92.0M | ||
| Q3 24 | — | $-70.7M | ||
| Q2 24 | — | $14.9M | ||
| Q1 24 | — | $-242.1M |
自由现金流BKVSRPT
| Q4 25 | — | $127.6M | ||
| Q3 25 | $-126.9M | $-37.5M | ||
| Q2 25 | — | $229.5M | ||
| Q1 25 | — | $-627.1M | ||
| Q4 24 | — | $54.0M | ||
| Q3 24 | — | $-108.0M | ||
| Q2 24 | — | $-14.2M | ||
| Q1 24 | — | $-274.5M |
自由现金流率BKVSRPT
| Q4 25 | — | 34.5% | ||
| Q3 25 | -63.5% | -10.1% | ||
| Q2 25 | — | 44.7% | ||
| Q1 25 | — | -102.5% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | -25.1% | ||
| Q2 24 | — | -3.9% | ||
| Q1 24 | — | -76.4% |
资本支出强度BKVSRPT
| Q4 25 | — | 1.0% | ||
| Q3 25 | 100.9% | 6.2% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 7.1% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 8.1% | ||
| Q1 24 | — | 9.0% |
现金转化率BKVSRPT
| Q4 25 | 0.99× | — | ||
| Q3 25 | 0.97× | — | ||
| Q2 25 | 0.73× | 1.33× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | — | -2.10× | ||
| Q2 24 | — | 2.31× | ||
| Q1 24 | — | -6.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BKV
| Natural Gas NGL And Oil | $249.3M | 97% |
| Related Party And Other | $4.7M | 2% |
| Marketing | $2.8M | 1% |
SRPT
| Pmo Products | $202.5M | 55% |
| Elevidys | $110.4M | 30% |
| Other | $56.7M | 15% |
